Publicaciones en colaboración con investigadores/as de National Cancer Institute (5)

1998

  1. Nm23 and tumour metastasis: Basic and translational advances

    Biochemical Society Symposium, Vol. 63, pp. 261-271

1997

  1. Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines

    Nature Medicine, Vol. 3, Núm. 4, pp. 395-401

  2. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro

    Journal of Biological Chemistry, Vol. 272, Núm. 9, pp. 5525-5532

1996

  1. Differential gene expression in tumor metastasis: Nm23

    Current Topics in Microbiology and Immunology, Vol. 213 II, pp. 215-232

  2. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells

    Journal of Biological Chemistry, Vol. 271, Núm. 41, pp. 25107-25116